UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Bowman & Co S.C.

Bowman & Co S.C. increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 28.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,936 shares of the healthcare conglomerate’s stock after buying an additional 861 shares during the quarter. UnitedHealth Group comprises 1.0% of Bowman & Co S.C.’s holdings, making the stock its 26th largest position. Bowman & Co S.C.’s holdings in UnitedHealth Group were worth $1,997,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Astoria Portfolio Advisors LLC. increased its position in shares of UnitedHealth Group by 5.5% during the fourth quarter. Astoria Portfolio Advisors LLC. now owns 3,611 shares of the healthcare conglomerate’s stock valued at $1,963,000 after acquiring an additional 189 shares during the last quarter. Kera Capital Partners Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $289,000. Financial Management Professionals Inc. boosted its holdings in UnitedHealth Group by 4.3% during the 4th quarter. Financial Management Professionals Inc. now owns 2,207 shares of the healthcare conglomerate’s stock valued at $1,116,000 after acquiring an additional 91 shares during the period. Raub Brock Capital Management LP increased its stake in UnitedHealth Group by 1.2% during the fourth quarter. Raub Brock Capital Management LP now owns 32,629 shares of the healthcare conglomerate’s stock worth $16,506,000 after purchasing an additional 393 shares during the period. Finally, Triangle Securities Wealth Management boosted its stake in shares of UnitedHealth Group by 18.6% in the fourth quarter. Triangle Securities Wealth Management now owns 4,887 shares of the healthcare conglomerate’s stock valued at $2,472,000 after purchasing an additional 767 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several brokerages have commented on UNH. Barclays decreased their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. Oppenheimer boosted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, Piper Sandler dropped their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Two equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Stock Performance

Shares of UNH opened at $510.03 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a 50-day simple moving average of $549.37 and a 200-day simple moving average of $562.73. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a market capitalization of $469.37 billion, a PE ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the firm posted $5.83 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.